Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Health bodies test digital interventions for diabetes
Health bodies test digital interventions for diabetes
NHS England, Public Health England and Diabetes UK have teamed up with leading companies from the tech sector to test new digital approaches to fighting type II diabetes.
New data show public support for tax rises to fund NHS
New data show public support for tax rises to fund NHS
Fifty-eight percent of adults talking part in a YouGov poll have backed a one percent rise in National Insurance tax to increase public spend on the NHS.
FDA widens scope of Pfizer’s Sutent in kidney cancer
FDA widens scope of Pfizer’s Sutent in kidney cancer
The US Food and Drug Administration has cleared Pfizer’s Sutent for adjuvant treatment of adults at a high risk of their kidney cancer returning after a kidney has been removed.
FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal
FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal
Today, the U.
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
One of the most promising fields of science is the area of cell-based therapies and their use in regenerative medicine.
FDA Approves Genentech’s HEMLIBRA (emicizumab-kxwh) for Hemophilia A with Inhibitors
FDA Approves Genentech’s HEMLIBRA (emicizumab-kxwh) for Hemophilia A with Inhibitors
SOUTH SAN FRANCISCO, Calif.
FDA approves treatment for rare genetic enzyme disorder
FDA approves treatment for rare genetic enzyme disorder
The U.
With new digital Abilify, big brother isn't watching—but your mother could be
With new digital Abilify, big brother isn't watching—but your mother could be
A new digital version of Abilify is the first-ever pill to notify patients that they've swallowed it.
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
It was only August when Merck and GlaxoSmithKline had to deal with a global shortage for their hepatitis B vaccines, and now unexpected demand in the U.
With only 2 warnings in 2017, pharma's ad police hits historic low
With only 2 warnings in 2017, pharma's ad police hits historic low
As the end of the year nears, the pharma industry can usually look back at FDA enforcement letters for insight into the agency's thinking and guidance on marketing communications.
EMA Recommends Ten Drugs for Approval
EMA Recommends Ten Drugs for Approval
At the November 2017 meeting of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), 10 new medicines were recommended for approval.
Dr. Reddy’s introduces generic Clolar injection
Dr. Reddy’s introduces generic Clolar injection
PRINCETON, N.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand